Veracyte, Inc. (VCYT)
44.06
+2.59
(+6.25%)
USD |
NASDAQ |
Aug 25, 16:00
44.06
0.00 (0.00%)
After-Hours: 16:23
Veracyte Price to Book Value : 2.550 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.400 |
| August 21, 2026 | 2.449 |
| August 20, 2026 | 2.419 |
| August 19, 2026 | 2.442 |
| August 18, 2026 | 2.355 |
| August 17, 2026 | 2.436 |
| August 14, 2026 | 2.388 |
| August 13, 2026 | 2.466 |
| August 12, 2026 | 2.586 |
| August 11, 2026 | 2.686 |
| August 10, 2026 | 2.678 |
| August 07, 2026 | 2.733 |
| August 06, 2026 | 2.671 |
| August 05, 2026 | 2.671 |
| August 04, 2026 | 2.686 |
| August 03, 2026 | 2.596 |
| July 31, 2026 | 2.681 |
| July 30, 2026 | 3.460 |
| July 29, 2026 | 3.225 |
| July 28, 2026 | 3.221 |
| July 27, 2026 | 3.219 |
| July 24, 2026 | 3.277 |
| July 23, 2026 | 3.350 |
| July 22, 2026 | 3.358 |
| July 21, 2026 | 3.446 |
| Date | Value |
|---|---|
| July 20, 2026 | 3.314 |
| July 17, 2026 | 3.423 |
| July 16, 2026 | 3.428 |
| July 15, 2026 | 3.445 |
| July 14, 2026 | 3.277 |
| July 13, 2026 | 3.327 |
| July 10, 2026 | 3.298 |
| July 09, 2026 | 3.432 |
| July 08, 2026 | 3.248 |
| July 07, 2026 | 3.251 |
| July 06, 2026 | 3.357 |
| July 02, 2026 | 3.304 |
| July 01, 2026 | 3.464 |
| June 30, 2026 | 3.399 |
| June 29, 2026 | 3.572 |
| June 26, 2026 | 3.590 |
| June 25, 2026 | 3.475 |
| June 24, 2026 | 3.369 |
| June 23, 2026 | 3.192 |
| June 22, 2026 | 3.157 |
| June 18, 2026 | 3.183 |
| June 17, 2026 | 3.044 |
| June 16, 2026 | 3.022 |
| June 15, 2026 | 2.917 |
| June 12, 2026 | 2.809 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Globus Medical, Inc. | 2.336 |
| Recursion Pharmaceuticals, Inc. | 2.075 |
| Anika Therapeutics, Inc. | 2.098 |
| Perspective Therapeutics, Inc. | 1.159 |
| Teleflex, Inc. | 2.043 |
Price to Book Value Related Metrics
| PE Ratio | 31.26 |
| PS Ratio | 6.360 |
| PEG Ratio | 0.0966 |
| Price to Free Cash Flow | 21.53 |
| Price | 44.06 |
| Earnings Yield | 3.20% |
| Market Cap | 3.541B |
| PEGY Ratio | 0.0966 |
| Operating PE Ratio | 36.93 |
| Normalized PE Ratio | 34.15 |